The results obtained from this pilot study suggested that analytes such as creatinine, urea, water, and albumin in urinary samples from patients with T2D can be identified by Raman spectroscopy by finding their corresponding Raman peaks. The gene discussed is ALB; the disease is type 2 diabetes mellitus.